Peptonic Medical (publ) today announced that Apotek Hjärtat is initiating sales of the company’s leading intimate care product VagiVital® AktivGel in most of its physical stores in Sweden, starting in May.
VagiVital® AktivGel is a treatment for vaginal atrophy and was the first product that Peptonic launched in intimate care. Peptonic intends to be a leading player in clinically proven intimate self-care, and there is a clear trend that people want to take greater responsibility for their own health with clinically proven self-care products.
“The need for and interest in VagiVital® AktivGel continues to grow, and we are pleased that Apotek Hjärtat now chooses to bring our product into its stores as well. This means that we strengthen our position in the important Swedish home market,” said Erik Sundquist, CEO of Peptonic Medical.
VagiVital® AktivGel is already sold online by all Swedish pharmacy operators and in all physical pharmacies with the exception of Apotek Hjärtat. The market for this type of treatment is growing by about 10% per year. In 2022, VagiVital AktivGel grew by more than +50% in Sweden compared to 2021 and increased its market share significantly, a growth that also forms the basis for Apotek Hjärtat’s decision to now bring VagiVital®AktivGel into ca 300 of its 400 physical stores, which represent just under 30% of the total number of physical pharmacies in Sweden.
“The fact that distribution is now being expanded to the majority of Apotek Hjärtat’s physical pharmacies is an important and significant step for continued rapid sales growth and increased distribution of Peptonic’s products in the important home market in Sweden,” said Erik Sundquist.
This disclosure contains information that PEPTONIC Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 12-04-2023 08:45 CET.
Erik Sundquist, CEO
Telefon: + 46 722 49 90 43
E-post: erik.sundquist@peptonicmedical.se
ABOUT Peptonic Medical AB
Peptonic is a Swedish innovative biomedical company that conducts research, development and sales of medical treatments and lifestyle products in the field of women’s health. Peptonic has divided its operations into two business areas: “Medical Consumer” and “Lifestyle Consumer”. The business area “Medical Consumer” is based on clinically proven intimate self-care and constitutes the company’s main focus and is sold under the VagiVital brand. The “Lifestyle Consumer” business area consists of lifestyle products with a focus on sustainable menstrual products and is sold under the Lunette brand. The company was founded in 2009 and the stock has been traded since 2014 on Spotlight (www.spotlightstockmarket.com) in Stockholm
